- Home
- OSUR vs SLDB Comparison
OSUR vs SLDB Comparison
Compare OSUR & SLDB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OSUR
- SLDB
- Stock Information
- Founded
- OSUR 2000
- SLDB 2013
- Country
- OSUR United States
- SLDB United States
- Employees
- OSUR N/A
- SLDB N/A
- Industry
- OSUR Medical/Dental Instruments
- SLDB Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- OSUR Health Care
- SLDB Health Care
- Exchange
- OSUR Nasdaq
- SLDB Nasdaq
- Market Cap
- OSUR 223.0M
- SLDB 234.8M
- IPO Year
- OSUR 1986
- SLDB 2018
- Fundamental
- Price
- OSUR $2.81
- SLDB $3.12
- Analyst Decision
- OSUR Hold
- SLDB Strong Buy
- Analyst Count
- OSUR 1
- SLDB 10
- Target Price
- OSUR $3.00
- SLDB $14.90
- AVG Volume (30 Days)
- OSUR 749.5K
- SLDB 1.9M
- Earning Date
- OSUR 05-07-2025
- SLDB 05-15-2025
- Dividend Yield
- OSUR N/A
- SLDB N/A
- EPS Growth
- OSUR N/A
- SLDB N/A
- EPS
- OSUR N/A
- SLDB N/A
- Revenue
- OSUR $161,626,000.00
- SLDB N/A
- Revenue This Year
- OSUR N/A
- SLDB N/A
- Revenue Next Year
- OSUR $6.87
- SLDB N/A
- P/E Ratio
- OSUR N/A
- SLDB N/A
- Revenue Growth
- OSUR N/A
- SLDB N/A
- 52 Week Low
- OSUR $2.36
- SLDB $2.41
- 52 Week High
- OSUR $4.98
- SLDB $10.37
- Technical
- Relative Strength Index (RSI)
- OSUR 51.01
- SLDB 50.14
- Support Level
- OSUR $2.71
- SLDB $3.10
- Resistance Level
- OSUR $3.01
- SLDB $3.32
- Average True Range (ATR)
- OSUR 0.16
- SLDB 0.25
- MACD
- OSUR 0.05
- SLDB 0.07
- Stochastic Oscillator
- OSUR 68.46
- SLDB 75.36
About OSUR OraSure Technologies Inc.
OraSure Technologies Inc is a medical devices company that develops, manufactures, and distributes oral fluid diagnostic and collection devices. Its reportable segments are diagnostics and molecular solutions. The diagnostics segment produces rapid oral diagnostic tests and specimen collection devices for infectious diseases such as HIV and HCV. The molecular solutions segment specializes in kits used to collect, stabilize, and transport genetic material samples for molecular testing of both hereditary diseases and infectious diseases, such as COVID-19. The company gets majority of its sales from the molecular solutions business, derived mainly from customers in the United States.
About SLDB Solid Biosciences Inc.
Solid Biosciences Inc is a life science company. It is engaged in the manufacturing of specialty and generic drugs. The company is involved in curing Duchenne muscular dystrophy (DMD), a genetic muscle-wasting disease predominantly affecting boys, with symptoms that usually manifest between three and five years of age. The company's pipeline products are the SB-001 and solid suit. The Company's singular focus is on developing treatments through gene therapy and other means for patients with neuromuscular and cardiac diseases. The company has categorized its programs into corrective therapies, disease-modifying therapies, and assistive devices.